GILDER GAGNON HOWE & CO LLC - UNITY BIOTECHNOLOGY INC ownership

UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 41 filers reported holding UNITY BIOTECHNOLOGY INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
GILDER GAGNON HOWE & CO LLC ownership history of UNITY BIOTECHNOLOGY INC
ValueSharesWeighting
Q1 2019$151,000
-53.5%
18,598
-6.8%
0.00%
-60.0%
Q4 2018$325,000
-0.3%
19,957
-0.2%
0.01%
+66.7%
Q3 2018$326,000
+8.3%
20,0000.0%0.00%0.0%
Q2 2018$301,00020,0000.00%
Other shareholders
UNITY BIOTECHNOLOGY INC shareholders Q2 2018
NameSharesValueWeighting ↓
Mayo Clinic 1,571,981$9,117,00023.05%
Invus Financial Advisors, LLC 2,189,998$12,702,0006.24%
Leap Investments LP 13,400$78,0000.11%
Moloney Securities Asset Management, LLC 51,950$301,0000.11%
Verity Asset Management, Inc. 14,748$86,0000.11%
Virtus ETF Advisers LLC 43,010$249,0000.10%
Investors Financial Group, LLC 15,850$92,0000.09%
SUNFLOWER BANK, NA WEALTH MANAGEMENT 20,000$116,0000.04%
Baillie Gifford 3,803,014$22,057,0000.02%
JACOBS LEVY EQUITY MANAGEMENT, INC 315,047$1,827,0000.02%
View complete list of UNITY BIOTECHNOLOGY INC shareholders